Differential expression of Notch1 intracellular domain and p21 proteins, and their clinical significance in gastric cancer

Oncology Letters

Volumn 7, Issue 2, 2014, Pages 471-478

  Luo, Ding Hai ^a,b   Zhou, Qin ^a   Hu, Sun Kuan ^a   Xia, Yi Qun ^a   Xu, Chao Chao ^a   Lin, Tie Su ^a   Pan, Yu Ting ^a   Wu, Jian Sheng ^a   Jin, Rong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Biomarkers; Gastric cancer; Notch1 intracellular doman; p21; Prognosis

Indexed keywords

NOTCH1 RECEPTOR; PROTEIN P21;

ADULT; ARTICLE; CANCER STAGING; CELL DEDIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; OVERALL SURVIVAL; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE; TUMOR INVASION; UPREGULATION;

EID: 84890334558     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1751     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Lin Y, Ueda J, Kikuchi S, et al: Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol17: 4421-4428, 2011.
3. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science284: 770-776, 1999.
4. Koch U and Radtke F: Notch and cancer: a double-edged sword. Cell Mol Life Sci 64: 2746-2762, 2007.
5. Stanley P: Regulation of Notch signaling by glycosylation. Curr Opin Struc Biol 17: 530-535, 2007.
6. Katoh M and Katoh M: Notch signaling in gastrointestinal tract (review). Int J Oncol 30: 247-251, 2007.
7. Sriuranpong V, Borges MW, Ravi RK, et al: Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 61: 3200-3205, 2001.
8. Duan L, Yao J, Wu X and Fan M: Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells. Biol Cell 98: 479-490, 2006.
9. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA and Chen H: Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J Biol Chem 281: 39819-39830, 2006.
10. Cayo MA, Cayo AK, Jarjour SM and Chen H: Sodium butyrate activates Notch1 signaling, reduces tumor markers, and induces cell cycle arrest and apoptosis in pheochromocytoma. Am JTransl Res 1: 178-183, 2009.
11. Greblatt DY, Vaccaro AM, Jaskula-Sztul R, et al: Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist 12: 942-951, 2007.
12. Kim SB, Chae GW, Lee J, et al: Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation. Cell Death Differ 14: 982-991, 2007.
13. Ning L, Wentworth L, Chen H and Weber SM: Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. Am J Transl Res 1: 358-366, 2009.
14. Tanaka M, Setoguchi T, Hirotsu M, et al: Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation. Br J Cancer 100: 1957-1965, 2009.
15. Guo D, Ye J, Dai J, et al: Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res 33: 678-685, 2009.
16. Massi D, Tarantini F, Franchi A, et al: Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Mod Pathol 19: 246-254, 2006.
17. Tarakji B and Nassani MZ: Immunohistochemical expression of p21 in normal tissues of salivary gland, pleomorphic adenoma and carcinoma ex pleomorphic adenoma-(undifferentiated and adenocarcinoma types). Med Oral Patol Oral Cir Bucal 15: e697-e703, 2010.
18. De La O JP, Emerson LL, Goodman JL, et al: Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci USA 105: 18907-18912, 2008.
19. Fre S, Huyghe M, Mourikis P, et al: Notch signals control the fate of immature progenitor cells in the intestine. Nature 435: 964-968, 2005.
20. Fan X, Matsui W, Khaki L, et al: Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66: 7445-7452, 2006.
21. Yeh TS, Wu CW, Hsu KW, et al: The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res 69: 5039-5048, 2009.
22. Garcia TX, Defalco T, Capel B and Hofmann MC: Constitutive activation of NOTCH1 signaling in Sertoli cells causes gonocyte exit from quiescence. Dev Biol 377: 188-201, 2013.
23. Piccin D, Yu F and Morshead C: Notch signaling imparts and preserves neural stem characteristics in the adult brain. Stem Cells Dev 22: 1541-1550, 2013.
24. Giambra V, Jenkins CR, Wang H, et al: NOTCH1 promotes Tcell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species. Nat Med 18: 1693-1698, 2012.
25. Simmons MJ, Serra R, Hermance N and Kelliher MA: NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro. Breast Cancer Res 14: R126, 2012.
26. Fassl A, Tagscherer KE, Richter J, et al: Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1. Oncogene 31: 4698-4708, 2012.
27. Skirnisdottir I and Seidal T: Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer. Cancer Genomics Proteomics 10: 27-34, 2013.
28. Place RF, Wang J, Noonan EJ, et al: Formulation of small activating RNA into lipidoid nanoparticles inhibits xenograft prostate tumor growth by inducing p21 expression. Mol Ther Nucleic Acids 1: e15, 2012.
29. Jee H, Lee SH, Park JW, et al: Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21Cip1 and p27Kip1. BMB Rep 46: 25-30, 2013.
30. Rowland BD and Peeper DS: KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 6: 11-23, 2006.
31. Devgan V, Mammucari C, Millar SE, et al: p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev 19: 1485-1495, 2005.
32. Götte M, Greve B, Kelsch R, et al: The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1. Int JCancer 129: 2042-2049, 2011.
33. Sarmento LM, Huang H, Limon A, et al: Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med 202: 157-168, 2005.
34. Li DW, Wu Q, Peng ZH, et al: Expression and significance of Notch1 and PTEN in gastric cancer. Ai Zheng 26: 1183-1187, 2007 (In Chinese).